Gyre Therapeutics (GYRE) Research & Development: 2010-2025
Historic Research & Development for Gyre Therapeutics (GYRE) over the last 15 years, with Sep 2025 value amounting to $2.4 million.
- Gyre Therapeutics' Research & Development fell 14.85% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year decrease of 2.21%. This contributed to the annual value of $12.0 million for FY2024, which is 12.74% down from last year.
- Per Gyre Therapeutics' latest filing, its Research & Development stood at $2.4 million for Q3 2025, which was down 31.01% from $3.4 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Research & Development registered a high of $20.4 million during Q3 2021, and its lowest value of $803,000 during Q3 2022.
- Its 3-year average for Research & Development is $3.2 million, with a median of $3.1 million in 2025.
- As far as peak fluctuations go, Gyre Therapeutics' Research & Development plummeted by 96.05% in 2022, and later surged by 274.72% in 2023.
- Over the past 5 years, Gyre Therapeutics' Research & Development (Quarterly) stood at $16.1 million in 2021, then slumped by 73.29% to $4.3 million in 2022, then climbed by 6.01% to $4.6 million in 2023, then decreased by 18.74% to $3.7 million in 2024, then fell by 14.85% to $2.4 million in 2025.
- Its Research & Development was $2.4 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.1 million in Q1 2025.